{
  "company": {
    "name": "Adaptam Therapeutics",
    "website": "https://adaptamtx.com/",
    "record": "https://startuphistory.org/c/adaptamtx.com"
  },
  "status": null,
  "history_since": "2024-12-10T09:40:23.000Z",
  "baseline": {
    "snapshot_id": "b9063a1588394145ed05689357ecbff5a688a8d8aebc3f6ee1ed4fdc0f3389c2",
    "observed_at": "2024-12-10T09:40:23.000Z",
    "headline": "MANTENIMIENTO - ADAPTAM",
    "description": "COMING SOON...",
    "evidence": "https://web.archive.org/web/20241210094023/https://adaptamtx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T09:40:07.153Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-12-10T09:40:23.000Z",
      "variants": [
        {
          "headline": "MANTENIMIENTO - ADAPTAM",
          "subhead": "COMING SOON...",
          "observed_at": "2024-12-10T09:40:23.000Z",
          "evidence": "https://web.archive.org/web/20241210094023/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "MANTENIMIENTO - ADAPTAM",
      "subhead": "COMING SOON...",
      "from": "2024-12-10T09:40:23.000Z",
      "to": "2024-12-10T09:40:23.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20241210094023/https://adaptamtx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2024-12-10T09:40:23.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-04T09:40:07.153Z",
      "variants": [
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2025-07-10T01:56:13.000Z",
          "evidence": "https://web.archive.org/web/20250710015613/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2025-11-01T02:18:39.000Z",
          "evidence": "https://web.archive.org/web/20251101021839/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2026-02-16T17:53:18.000Z",
          "evidence": "https://web.archive.org/web/20260216175318/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2026-04-19T08:44:14.000Z",
          "evidence": "https://web.archive.org/web/20260419084414/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2026-06-10T12:47:35.000Z",
          "evidence": "https://web.archive.org/web/20260610124735/https://adaptamtx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
          "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
          "observed_at": "2026-11-04T09:40:07.153Z",
          "evidence": "https://adaptamtx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Disrupting the immunosuppressive myeloid microenvironment unlocks the next era of cancer immunotherapy",
      "subhead": "Adaptam Therapeutics brings better therapies to oncology patients thanks to immunotherapies that target the immunosuppressive myeloid tumor.",
      "from": "2025-07-10T01:56:13.000Z",
      "to": "2026-11-04T09:40:07.153Z",
      "captures": 6,
      "evidence": "https://adaptamtx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-07-10T01:56:13.000Z",
          "to": "2026-11-04T09:40:07.153Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-c3b5bc81eb2c5053c521e0725c2388d979d3bf2fc4a290268be261a0746da8f3:f0ef2ab86290caaca217c03844c02860559290cfd4d04913a5ce6578b37910a3:funding:68bdde1071fa4dc0",
      "before_evidence": "https://web.archive.org/web/20250710015613/https://adaptamtx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “& FUNDING AGENCIES Public Funding NEWS Adaptam Therapeutics raises €3 million to pioneer cancer immunotherapi...”.",
      "between": {
        "from": "2025-07-10T01:56:13.000Z",
        "to": "2025-11-01T02:18:39.000Z"
      },
      "evidence": "https://web.archive.org/web/20251101021839/https://adaptamtx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Adaptam Therapeutics” company record, https://startuphistory.org/c/adaptamtx.com"
}